Erik Blomquist

1.8k total citations
70 papers, 1.4k citations indexed

About

Erik Blomquist is a scholar working on Radiology, Nuclear Medicine and Imaging, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Erik Blomquist has authored 70 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Radiology, Nuclear Medicine and Imaging, 20 papers in Genetics and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Erik Blomquist's work include Glioma Diagnosis and Treatment (18 papers), Radiation Therapy and Dosimetry (11 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Erik Blomquist is often cited by papers focused on Glioma Diagnosis and Treatment (18 papers), Radiation Therapy and Dosimetry (11 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Erik Blomquist collaborates with scholars based in Sweden, Denmark and United States. Erik Blomquist's co-authors include Erik Grusell, Bengt Glimelius, Anders Montelius, Ulf Isacsson, Bo Stenerlöw, Jörgen Carlsson, Jonas Johansson, J. Carlsson, Roger Henriksson and Anders Lilja and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Erik Blomquist

69 papers receiving 1.4k citations

Peers

Countries citing papers authored by Erik Blomquist

Since Specialization

Citations

This map shows the geographic impact of Erik Blomquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Blomquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Blomquist more than expected).

Fields of papers citing papers by Erik Blomquist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Blomquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Blomquist. The network helps show where Erik Blomquist may publish in the future.

Co-authorship network of co-authors of Erik Blomquist

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Blomquist. A scholar is included among the top collaborators of Erik Blomquist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Blomquist. Erik Blomquist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perfusion magnetic resonance imaging changes in normal appearing brain tissue after radiotherapy in glioblastoma patients may confound longitudinal evaluation of treatment response 2018 ·Radiology and Oncology ·Markus Fahlström, Erik Blomquist, Tufve Nyholm, Elna‐Marie Larsson	10
2	Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas 2017 ·Acta Neurochirurgica ·(unknown), Olafur Gudjonsson, Anders Montelius, Erik Grusell, Ulf Isacsson, Kristina Nilsson, Erik Blomquist	22
3	Positive correlation between occlusion rate and nidus size of proton beam treated brain arteriovenous malformations (AVMs) 2015 ·Acta Oncologica ·Erik Blomquist, Elisabeth Ronne-Engström, (unknown), Gyula Gál, Kristina Nilsson, Anders Lewén, Anders Montelius, Erik Grusell, Ulf Isacsson, Per Enblad	6
4	Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) 2008 ·Radiotherapy and Oncology ·Roger Henriksson, Jacek Capala, Annika Michanek, (unknown), Leif G. Salford, Lars Franzén, Erik Blomquist, Jan‐Erik Westlin, A. Tommy Bergenheim	123
5	Clinical impact of positron emission tomography (PET) with (¹⁸F)fluorodeoxyglucose (FDG) in head and neck tumours 2006 ·Acta Oto-Laryngologica ·(unknown), Jens Christian Hedemann Sørensen, Mats Engström, Erik Blomquist, Anders Sundin, Matti Anniko	4
6	Number of patients potentially eligible for proton therapy 2005 ·Acta Oncologica ·Bengt Glimelius, (unknown), Göran Bjelkengren, Thomas Björk‐Eriksson, Erik Blomquist, Bengt Johansson, Mikael Karlsson, Björn Zackrisson	65
7	The potential of proton beam radiation therapy in intracranial and ocular tumours 2005 ·Acta Oncologica ·Erik Blomquist, Göran Bjelkengren, Bengt Glimelius	6
8	[ ¹⁷⁷ Lu]Bz-DTPA-EGF: Preclinical Characterization of a Potential Radionuclide Targeting Agent Against Glioma 2004 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), Lars Gedda, Anna Orlova, Alexander Bruskin, Erik Blomquist, Jörgen Carlsson, Vladimir Tolmachev	15
9	Fractionated, stereotactic proton beam treatment of cerebral arteriovenous malformations 2004 ·Acta Neurologica Scandinavica ·Hans C son Silander, Luigi Pellettieri, Per Enblad, Anders Montelius, Erik Grusell, (unknown), Ulf Isacsson, Gunnar Nyberg, Ulf Moström, Anders Lilja, Gyula Gál, Erik Blomquist	45
10	[ ¹¹¹ In]Bz-DTPA-hEGF: Preparation and In Vitro Characterization of a Potential Anti-Glioblastoma Targeting Agent 2003 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), Anna Orlova, Alexander Bruskin, Lars Gedda, Jörgen Carlsson, Erik Blomquist, Hans Lundqvist, Vladimir Tolmachev	15
11	Cellular retention of radioactivity and increased radiation dose. Model experiments with EGF-dextran 2003 ·Nuclear Medicine and Biology ·(unknown), Erik Blomquist, Jörgen Carlsson, Ann-Charlott Steffen, Lars Gedda	14
12	A Systematic Overview of Radiation Therapy Effects in Brain Tumours 2003 ·Acta Oncologica ·Gertrud E. B. Berg, Erik Blomquist, Eva Cavallin‐Ståhl	26
13	Differences in radiosensitivity between brain, small and large arteriovenous malformations 1999 ·Medical Hypotheses ·Luigi Pellettieri, Erik Blomquist	4
14	Proton Irradiation of Malignant Uveal Melanoma 1998 ·Upsala Journal of Medical Sciences ·Peter Naeser, Erik Blomquist, Anders Montelius, (unknown)	7
15	Rejoining of clustered double-strand breaks induced by high-LET radiation. 1997 ·Radiation Research ·Bo Stenerlöw, (unknown), J. Carlsson, Erik Blomquist	2
16	Irregular variations in radiation sensitivity when the linear energy transfer is increased 1995 ·Radiotherapy and Oncology ·Bo Stenerlöw, (unknown), Magnus Essand, Erik Blomquist, Jörgen Carlsson	27
17	Clonogenic Cell Survival and Rejoining of DNA Double-strand Breaks: Comparisons between Three Cell Lines after Photon or He Ion Irradiation 1994 ·International Journal of Radiation Biology ·Bo Stenerlöw, J. Carlsson, Erik Blomquist, Klaus Erixon	43
18	Relative biological effectiveness of intermediate energy protons. Comparisons with 60Co gamma-radiation using two cell lines 1993 ·Radiotherapy and Oncology ·Erik Blomquist, Kellie R. Russell, Bo Stenerlöw, Anders Montelius, Erik Grusell, (unknown)	52
19	Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group. 1991 ·Journal of Clinical Oncology ·L Hafström, C.-M. Rudenstam, Erik Blomquist, Christian Ingvar, Jönsson Pe, B. Lagerlöf, C. Lindholm, Ulrik Ringborg, Gunnar Westman, Leif T. Östrup	104
20	Failure of betamethasone to alter the radiation response of two cultured human glioma cell-lines 1990 ·Journal of Neuro-Oncology ·(unknown), Erik Blomquist, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact